FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCardio Diagnostics Holdings, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CDIO
Cardio Diagnostics Holdings, Inc. Stock AnalysisComprehensive stock analysis for Cardio Diagnostics Holdings, Inc. (CDIO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCDIO
CDIO
Cardio Diagnostics Holdings, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CDIO
  1. Home
  2. Stocks
  3. Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc.

🇺🇸CDIO•NASDAQ

Cardio Diagnostics Holdings, Inc.

🇺🇸CDIO•NASDAQ
Market cap
$4.74M

Your view on CDIO

Mkt Cap
$4.74M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cardio Diagnostics Holdings, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Meeshanthini V. Dogan
Headquarters
400 N Aberdeen St, Chicago, IL, US
Industry
Biotechnology
Sector
Healthcare
CEO
Meeshanthini V. Dogan
Headquarters
400 N Aberdeen St, Chicago, IL, US
Description

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Cardio Diagnostics Holdings, Inc.. Starting points for Cardio Diagnostics Holdings, Inc.: EPS -$2.19, beta 2.27 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Cardio Diagnostics Holdings, Inc.. Trailing twelve-month EPS for Cardio Diagnostics Holdings, Inc. stands at -$2.19. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026

Buy

Analyst ratings

1 rating
  • Strong Buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong Sell0
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026
Average estimate−$19.80−$19.80−$16.50
Lowest estimate−$19.80−$19.80−$16.50
Highest estimate−$19.80−$19.80−$16.50
Number of analysts111
A year ago−$0.98−$0.801−$3.711
Growth vs a year ago−1920.4%——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026
Average estimate$100000.00$100000.00$25.00M
Lowest estimate$100000.00$100000.00$25.00M
Highest estimate$100000.00$100000.00$25.00M
Number of analysts111
A year ago$2855.00$3555.00$14825.00
Growth vs a year ago+3402.6%+2712.9%+168534.1%
Recent rating and target changes (4)

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Cardio Diagnostics Holdings, Inc.. Cardio Diagnostics Holdings, Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CDIO20 companies · 1 funds
Compare CDIO with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
ADILAdial Pharmaceuticals, Inc.HealthcareBiotechnology$13.3M
ADXNAddex Therapeutics LtdHealthcareBiotechnology$4.3M
BCDABioCardia, Inc.HealthcareBiotechnology$11.9M
BCLIBrainstorm Cell Therapeutics Inc.HealthcareBiotechnology$6.8M
CELZCreative Medical Technology Holdings, Inc.HealthcareBiotechnology$3.1M
IBOImpact BioMedical Inc.HealthcareBiotechnology$52.8M
MTNBMatinas BioPharma Holdings, Inc.HealthcareBiotechnology$341,620
NRSNNeuroSense Therapeutics Ltd.HealthcareBiotechnology$2.4M
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
VPROViropro Inc.HealthcareOTC$25,404
VRAXVirax Biolabs Group LimitedHealthcareNASDAQ$446,402
VRCAVerrica Pharmaceuticals Inc.HealthcareNASDAQ$47.1M
VRCIVerde Science, Inc.HealthcareOTC$239
VRDNViridian Therapeutics, Inc.HealthcareNASDAQ$3.4B
VRPXVirpax Pharmaceuticals, Inc.HealthcareNASDAQ$26,093
VRTXVertex Pharmaceuticals IncorporatedHealthcareNASDAQ$130.6B
VRXAVeraxa Biotech Holding AGHealthcareNASDAQ$147.1M
VRXAWVeraxa Biotech AGHealthcareNASDAQ$667,920
SPRCSciSparc Ltd.HealthcareNASDAQ$113,580
SPROSpero Therapeutics, Inc.HealthcareNASDAQ$43.2M
SPRYARS Pharmaceuticals, Inc.HealthcareNASDAQ$297.6M
ETFs holding Cardio Diagnostics Holdings, Inc.
TickerFundFund assets% of the fund
VXFVanguard Extended Market ETF$30.2B in assets0.00%

Largest holders first, then the funds most concentrated in CDIO.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Cardio Diagnostics Holdings, Inc., and how their positions are changing. At a $4.7M market value, institutional positions materially move Cardio Diagnostics Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Cardio Diagnostics Holdings, Inc. executives and directors. Shares of Cardio Diagnostics Holdings, Inc. have traded between $2.73 and $53.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Cardio Diagnostics Holdings, Inc.. Coverage tracks Cardio Diagnostics Holdings, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Cardio Diagnostics Holdings, Inc.

CDIO AnalysisFair
Past
1
Growth
5
Health
5
Profit
1
Value
1